Friday, February 21, 2025 10:52:22 AM
Anyone who follows this board can see which posters show up along with the volume spike. I'd give you the list of names, but my post would be immediately deleted by "some unknown entity". So, you need to learn how to do your own due diligence. I think its funny how you characterize people as "longs" or "bashers", as if there is no opposite word for "basher". Perhaps "pumper" would work.
Do you also include in your list of opposites such terms as "hate " and "like"? You can go ahead and say it, everyone knows already. The opposite of basher is pumper. Can't believe in one without believing in the other.
All ya' gotta do is go look at what other boards certain posters post and see how those "recommendations" have done over time. The only real positive to IHUB is storing history and you're not even using it.
BTW, the guy you are chastising has been correct about the direction of the stock for years. The least you can do is thank him for warning newbies not to throw away money.
PS.....if you know how to read a tape you'd know these are all sells.....
02/21/25 10:58:49 AM 5 10000 0.2592
02/21/25 10:56:59 AM 5 22769 0.2546
02/21/25 10:56:59 AM 5 2231 0.2515
02/21/25 10:56:27 AM 5 10000 0.2600
02/21/25 10:56:27 AM 5 10000 0.2582
02/21/25 10:55:38 AM 5 2444 0.2599
02/21/25 10:55:38 AM 5 2444 0.2599
02/21/25 10:55:32 AM 5 1000 0.2600
02/21/25 10:54:49 AM 5 2364 0.2600
02/21/25 10:54:40 AM 5 100 0.2600
02/21/25 10:54:40 AM 5 2500 0.2599
02/21/25 10:54:40 AM 5 2500 0.2599
02/21/25 10:54:23 AM 5 8500 0.2599
02/21/25 10:51:56 AM 5 2000 0.2599
02/21/25 10:51:01 AM 5 100 0.2600
02/21/25 10:46:42 AM 5 0.2501 5 0.2649 89 X 150 BBO
02/21/25 10:46:42 AM 5 0.2501 5 0.2649 89 X 125 BBO
02/21/25 10:46:42 AM 5 0.2501 5 0.2649 89 X 100 BBO
02/21/25 10:45:37 AM 5 0.2501 5 0.2650 89 X 410 BBO
02/21/25 10:45:35 AM 5 0.2501 5 0.2650 89 X 385 BBO
02/21/25 10:45:35 AM 5 0.2501 5 0.2650 89 X 360 BBO
Just my opinion, of course.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
